Prelude Therapeutics Incorporated
NASDAQ:PRLD
0.8 (USD) • At close July 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||||||||
| Current Assets: | |||||||||||||||||||||||
| Cash & Cash Equivalents
| 40.269 | 12.474 | 11.134 | 27.828 | 24.707 | 25.291 | 15.896 | 26.446 | 18.201 | 30.605 | 52.022 | 50.706 | 51.634 | 31.828 | 61.424 | 343.119 | 362.99 | 218.309 | 234.792 | 29.716 | -18.879 | 18.879 | -15.595 |
| Short Term Investments
| 58.805 | 121.14 | 142.492 | 152.016 | 177.217 | 207.644 | 214.61 | 228.543 | 154.054 | 171.123 | 172.021 | 195.599 | 214.555 | 259.405 | 259.441 | 0 | 0 | 0 | 0 | 0 | 37.758 | 0 | 31.19 |
| Cash and Short Term Investments
| 99.074 | 133.614 | 153.626 | 179.844 | 201.924 | 232.935 | 230.506 | 254.989 | 172.255 | 201.728 | 224.043 | 246.305 | 266.189 | 291.233 | 320.865 | 343.119 | 362.99 | 218.309 | 234.792 | 29.716 | 18.879 | 18.879 | 15.595 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.329 | 2.281 | 2.761 | 2.87 | 3.442 | 2.654 | 4.41 | 5.221 | 3.008 | 2.652 | 5.7 | 4.638 | 3.783 | 3.882 | 10.064 | 2.912 | 4.056 | 5 | 6.538 | 0.981 | 0 | 1.345 | 0 |
| Total Current Assets
| 102.403 | 135.895 | 156.387 | 182.714 | 205.366 | 235.589 | 234.916 | 260.21 | 175.263 | 204.38 | 226.893 | 248.624 | 269.972 | 295.115 | 325.897 | 344.575 | 365.018 | 220.809 | 238.061 | 30.697 | 18.879 | 20.224 | 15.595 |
| Non-Current Assets: | |||||||||||||||||||||||
| Property, Plant & Equipment, Net
| 34.703 | 35.466 | 36.384 | 37.128 | 37.401 | 37.737 | 7.082 | 7 | 6.731 | 6.7 | 6.464 | 6.078 | 6.346 | 5.636 | 5.32 | 5.006 | 4.813 | 2.48 | 1.62 | 1.575 | 0 | 1.647 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 4.044 | 4.044 | 4.044 | 4.044 | 4.044 | 17.069 | 4.044 | 4.044 | 4.044 | 4.044 | 259.405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.154 | 4.154 | 4.449 | 0.405 | 0.295 | 0.295 | 12.469 | 9.357 | -0.743 | 5.376 | 4.926 | 0.309 | 0.309 | -255.058 | 0 | 0 | 0 | 0.301 | 0 | 0.475 | -18.879 | 0 | -15.595 |
| Total Non-Current Assets
| 38.857 | 39.62 | 40.833 | 41.577 | 41.74 | 42.076 | 23.595 | 20.401 | 23.057 | 16.12 | 15.434 | 10.431 | 10.699 | 9.983 | 5.32 | 5.006 | 4.813 | 2.781 | 1.62 | 2.05 | -18.879 | 1.647 | -15.595 |
| Total Assets
| 141.26 | 175.515 | 197.22 | 224.291 | 247.106 | 277.665 | 258.511 | 280.611 | 198.32 | 220.5 | 242.327 | 259.055 | 280.671 | 305.098 | 331.217 | 349.581 | 369.831 | 223.59 | 239.681 | 32.747 | 0 | 21.871 | 0 |
| Liabilities & Equity: | |||||||||||||||||||||||
| Current Liabilities: | |||||||||||||||||||||||
| Account Payables
| 5.831 | 7.732 | 5.921 | 6.17 | 5.308 | 4.58 | 5.17 | 5.585 | 7.082 | 6.777 | 10.25 | 6.273 | 7.39 | 7.84 | 11.062 | 6.844 | 4.842 | 3.92 | 5.074 | 3.471 | 0 | 1.974 | 0 |
| Short Term Debt
| 2.653 | 2.7 | 2.724 | 5.478 | 2.188 | 2.962 | 0.95 | 1.876 | 2.78 | 3.664 | 2.776 | 3.644 | 3.718 | 3.48 | 3.672 | 2.806 | 2.806 | 0 | 0 | 0.067 | 0 | 0.258 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 3 | -5.308 | 14.823 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.067 | 0 | -0.258 | 0 |
| Other Current Liabilities
| 11.303 | 15.209 | 13.579 | 8.687 | 10.147 | 14.287 | 10.773 | 7.729 | 9.8 | 11.261 | 8.534 | 5.894 | 4.961 | 7.881 | 4.929 | 5.027 | 4.776 | 7.455 | 6.285 | 2.101 | 0 | 2.603 | 0 |
| Total Current Liabilities
| 19.787 | 25.641 | 22.224 | 23.335 | 17.643 | 21.829 | 16.893 | 15.19 | 19.662 | 21.702 | 21.56 | 15.811 | 16.069 | 19.201 | 19.663 | 14.677 | 12.424 | 11.375 | 11.359 | 5.639 | 0 | 4.835 | 0 |
| Non-Current Liabilities: | |||||||||||||||||||||||
| Long Term Debt
| 15.267 | 15.325 | 15.412 | 15.465 | 15.452 | 15.407 | 0 | 0 | 0 | 0 | 0 | 0 | 0.39 | 0 | 0.312 | 0.543 | 0.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.028 | 3.09 | 3.153 | 3.215 | 3.277 | 3.339 | 3.361 | 3.361 | 3.361 | 3.361 | 3.36 | 2.4 | 2.4 | 0 | 0 | 0 | 0 | 0.032 | 0.015 | 96.419 | 0 | 66.448 | 0 |
| Total Non-Current Liabilities
| 18.295 | 18.415 | 18.565 | 18.68 | 18.729 | 18.746 | 3.361 | 3.361 | 3.361 | 3.361 | 3.36 | 2.4 | 2.79 | 9.58 | 0.312 | 0.543 | 0.84 | 0.032 | 0.015 | 96.419 | 0 | 66.448 | 0 |
| Total Liabilities
| 38.082 | 44.056 | 40.789 | 42.015 | 36.372 | 40.575 | 20.254 | 18.551 | 23.023 | 25.063 | 24.92 | 18.211 | 18.859 | 19.201 | 19.975 | 15.22 | 13.264 | 11.407 | 11.374 | 102.058 | 0 | 71.283 | 0 |
| Equity: | |||||||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 239.681 | 96.385 | 66.443 | 66.443 | 36.595 |
| Common Stock
| 0.005 | 0.005 | 0.004 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -615.648 | -583.563 | -554.832 | -522.561 | -487.821 | -456.39 | -423.315 | -392.707 | -362.276 | -334.558 | -305.917 | -275.959 | -248.585 | -219.12 | -186.278 | -155.591 | -128.726 | -107.426 | -88.176 | -71.416 | 0 | -50.497 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.012 | 0.035 | 0.167 | -0.29 | -0.235 | 0.223 | -0.605 | -0.711 | -0.398 | -1.692 | -2.363 | -2.294 | -2.313 | -0.711 | -0.176 | 0 | 0 | -0 | -239.681 | -0 | -49.412 | -0.556 | -22.693 |
| Other Total Stockholders Equity
| 718.809 | 714.982 | 711.092 | 705.122 | 698.785 | 693.252 | 662.172 | 655.473 | 537.966 | 531.682 | 525.682 | 519.092 | 512.705 | 505.723 | 497.691 | 489.947 | 485.288 | 319.605 | 76.798 | -94.28 | 0 | 1.641 | 0 |
| Total Shareholders Equity
| 103.178 | 131.459 | 156.431 | 182.276 | 210.734 | 237.09 | 238.257 | 262.06 | 175.297 | 195.437 | 217.407 | 240.844 | 261.812 | 285.897 | 311.242 | 334.361 | 356.567 | 212.183 | 228.307 | -69.311 | 17.031 | -49.412 | 13.902 |
| Total Equity
| 103.178 | 131.459 | 156.431 | 182.276 | 210.734 | 237.09 | 238.257 | 262.06 | 175.297 | 195.437 | 217.407 | 240.844 | 261.812 | 285.897 | 311.242 | 334.361 | 356.567 | 212.183 | 228.307 | -69.311 | 17.031 | -49.412 | 13.902 |
| Total Liabilities & Shareholders Equity
| 141.26 | 175.515 | 197.22 | 224.291 | 247.106 | 277.665 | 258.511 | 280.611 | 198.32 | 220.5 | 242.327 | 259.055 | 280.671 | 305.098 | 331.217 | 349.581 | 369.831 | 223.59 | 239.681 | 32.747 | 17.031 | 21.871 | 13.902 |